adherence
Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
Publication year: 2011Source: Schizophrenia Research, Available online 30 November 2011Jaewon Yang, Young-Hoon Ko, Jong-Woo Paik, Moon-Soo Lee, Changsu Han, ...
Race and Residential Socioeconomics as Predictors of CPAP Adherence
There are few established predictors of CPAP adherence; poor adherence limits its effectiveness. We investigated whether race, education level, and residential economic status predict CPAP adherence in participants enrolled in a trial with standard access to treatment.
A multi-center randomized trial of home vs. lab-based evaluation and treatment of OSA assessing adherence to CPAP at 1 and 3 months.
Improving Adherence - Money Isn't the Only Thing.
Goldman L, Epstein AM | | |
Mirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial [Original Article]
Context No approved pharmacologic treatments for methamphetamine dependence exist. Methamphetamine use is associated with high morbidity and is a major cofactor in the human immunodeficiency virus epidemic among men who have sex with men (MSM).
Objective To determine whether mirtazapine would reduce methamphetamine use among MSM who are actively using methamphetamine.
Design Double-blind, randomized, controlled, 12-week trial of mirtazapine vs placebo conducted from September 5, 2007, to March 4, 2010.
Ethnic Disparities in CPAP Adherence in New Zealand: Effects of Socioeconomic Status, Health Literacy and Self-Efficacy
We aimed to investigate the influence of ethnicity on adherence with continuous positive airway pressure (CPAP) in a sample of New Zealand patients.
Observational study over one month.
A university-based sleep laboratory.
126 consecutively consenting CPAP-naïve patients (19.8% Māori, mean±SD apnea-hypopnea index 57.9 ± 38.9 events/h, CPAP 11.1 ± 3.1 cm H2O).
Does Treatment Adherence Therapy reduce expense of healthcare use in patients with psychotic disorders? Cost-minimization analysis in a randomized controlled trial
Publication year: 2011Source: Schizophrenia Research, Available online 13 October 2011J. Gilden, A.B.P. Staring, M. van der Gaag, C.L. Mulder
